Related Experiment Video

Updated: Apr 25, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

7.6K

NEK9-dependent proliferation of cancer cells lacking functional p53

Daisuke Kurioka1, Fumitaka Takeshita2, Koji Tsuta3

  • 11] Division of Genome Biology, National Cancer Center Research Institute [2] Laboratory for Medical Engineering, Division of Materials and Chemical Engineering, Graduate School of Engineering, Yokohama National University, 79-1 Tokiwadai, Hodogaya-ku Yokohama 240-8501, Japan.

Scientific Reports
|August 19, 2014
PubMed

Insights

Researchers identified NIMA-related kinase 9 (NEK9) as a key regulator in p53-inactivated cancer cells. NEK9 depletion inhibits cancer cell proliferation and survival, offering a potential therapeutic target for these tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Dysfunctional p53 network is a primary driver of cancer development.
  • Targeting p53-inactivated cancer cells is a promising therapeutic strategy.

Purpose of the Study:

  • Identify novel regulators of p53-deficient cancer cell proliferation.
  • Investigate the role of NEK9 in p53-inactivated cancers.

Main Methods:

  • MicroRNA target screen to identify NEK9.
  • In vitro and in vivo experiments to assess NEK9 depletion effects.
  • Analysis of gene expression and patient prognosis data.

Main Results:

  • NEK9 depletion selectively inhibited proliferation in p53-deficient cancer cells.
  • Cell-cycle arrest in G1 phase with senescence-like features was observed.
  • NEK9 repression impacted cell-cycle regulators and mRNA processing genes.
  • High NEK9 and mutant p53 expression correlated with poorer prognosis in lung adenocarcinoma.

Conclusions:

  • NEK9 is a crucial regulator of cell-cycle progression in p53-inactivated cancer cells.
  • A novel NEK9 network promotes the growth of cancers lacking functional p53.
  • NEK9 represents a potential therapeutic target for p53-deficient cancers.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K
Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

8.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

2.9K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K